このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Globus Medical 将来の成長

Future 基準チェック /46

Globus Medical利益と収益がそれぞれ年間40.9%と11.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に10.2% 39.9%なると予測されています。

主要情報

53.3%

収益成長率

53.0%

EPS成長率

Medical Equipment 収益成長	0%
収益成長率	8.4%
将来の株主資本利益率	10.7%
アナリストカバレッジ	Good
最終更新日	27 Sep 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BMV:GMED * - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	2,845	441	N/A	N/A	10
12/31/2025	2,656	384	692	N/A	14
12/31/2024	2,484	124	34	N/A	13
6/30/2024	2,237	41	161	262	N/A
3/31/2024	1,898	67	152	243	N/A
12/31/2023	1,568	123	165	243	N/A
9/30/2023	1,226	158	129	203	N/A
6/30/2023	1,097	204	121	185	N/A
3/31/2023	1,069	201	117	187	N/A
12/31/2022	1,023	190	104	178	N/A
9/30/2022	998	155	118	191	N/A
6/30/2022	974	155	157	235	N/A
3/31/2022	961	142	194	257	N/A
12/31/2021	958	149	219	276	N/A
9/30/2021	942	187	226	280	N/A
6/30/2021	928	184	203	256	N/A
3/31/2021	826	122	165	220	N/A
12/31/2020	789	102	135	199	N/A
9/30/2020	767	95	108	173	N/A
6/30/2020	747	89	115	176	N/A
3/31/2020	793	148	110	175	N/A
12/31/2019	785	155	101	172	N/A
9/30/2019	770	146	90	162	N/A
6/30/2019	743	143	82	158	N/A
3/31/2019	722	150	93	169	N/A
12/31/2018	713	156	122	182	N/A
9/30/2018	693	144	126	182	N/A
6/30/2018	676	134	112	165	N/A
3/31/2018	655	118	N/A	158	N/A
12/31/2017	636	107	N/A	159	N/A
9/30/2017	612	107	N/A	166	N/A
6/30/2017	595	108	N/A	174	N/A
3/31/2017	581	105	N/A	171	N/A
12/31/2016	564	104	N/A	148	N/A
9/30/2016	553	118	N/A	166	N/A
6/30/2016	554	118	N/A	153	N/A
3/31/2016	548	116	N/A	143	N/A
12/31/2015	537	113	N/A	124	N/A
9/30/2015	518	103	N/A	80	N/A
6/30/2015	499	99	N/A	85	N/A
3/31/2015	481	96	N/A	85	N/A
12/31/2014	467	92	N/A	79	N/A
9/30/2014	454	86	N/A	110	N/A
6/30/2014	443	83	N/A	108	N/A
3/31/2014	436	70	N/A	104	N/A
12/31/2013	427	69	N/A	93	N/A
9/30/2013	420	68	N/A	86	N/A

アナリストによる今後の成長予測

収入対貯蓄率: GMED *の予測収益成長率 (年間40.9% ) は貯蓄率 ( 7.8% ) を上回っています。

収益対市場: GMED *の収益 ( 40.9% ) はMX市場 ( 11.6% ) よりも速いペースで成長すると予測されています。

高成長収益: GMED *の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: GMED *の収益 ( 11.2% ) MX市場 ( 7% ) よりも速いペースで成長すると予測されています。

高い収益成長: GMED *の収益 ( 11.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: GMED *の自己資本利益率は、3年後には低くなると予測されています ( 10.2 %)。

Globus Medical 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Globus Medical, Inc. Revises Earnings Guidance for the Year 2024

Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024

Globus Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2024

Globus Medical, Inc. Revises Earnings Guidance for the Year 2023

Globus Medical, Inc. Updates Earnings Guidance for the Year 2023

Globus Medical, Inc. Provides Earnings Guidance for the Full Year 2023

Recent updates

Globus Medical, Inc. Launches ADIRA™? XLIF™? Plate System

Globus Medical, Inc. Revises Earnings Guidance for the Year 2024

Globus Medical, Inc. Receives FDA 510(k) Clearance for Excelsiusflex™? and ACTIFY™? 3D Total Knee System

Globus Medical, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Value-Defensive Index

Independent Director recently sold Mex$12m worth of stock

First quarter 2024 earnings released: US$0.053 loss per share (vs US$0.49 profit in 1Q 2023)

Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024

Globus Medical, Inc., Annual General Meeting, Jun 05, 2024

Globus Medical, Inc. to Report Q1, 2024 Results on May 07, 2024

Globus Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2024

Globus Medical Promotes Keith Pfeil to Chief Operating Officer

Globus Medical, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Globus Medical, Inc. Revises Earnings Guidance for the Year 2023

Globus Medical, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Globus Medical, Inc. (NYSE:GMED) completed the acquisition of NuVasive, Inc. (NasdaqGS:NUVA) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., Thrivent Financial for Lutherans and others.

Globus Medical, Inc. Updates Earnings Guidance for the Year 2023

Globus Medical, Inc. Announces Launch of the Marvel(Tm) Growing Rod System

Globus Medical, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Globus Medical, Inc.(NYSE:GMED) dropped from Russell 1000 Growth-Defensive Index

Insufficient new directors

Globus Medical, Inc. Provides Earnings Guidance for the Full Year 2023

Insufficient new directors

Full year 2022 earnings released: EPS: US$1.89 (vs US$1.48 in FY 2021)

Globus Medical, Inc. (NYSE:GMED) entered into a definitive agreement to acquire NuVasive, Inc. (NasdaqGS:NUVA) for $3.1 billion.

Globus Medical, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Insufficient new directors

Globus Medical, Inc. Reaffirms Net Sales Guidance for the Year 2022

Globus Medical, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Globus Medical, Inc. Reaffirms Sales Guidance for the Full Year 2022

Globus Medical, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Globus Medical, Inc. Announces First Surgeries Using Excelsius3D™

Globus Medical, Inc., Annual General Meeting, Jun 02, 2022

Globus Medical, Inc. to Report Q1, 2022 Results on May 10, 2022

Globus Medical, Inc. Provides Net Sales Guidance for the Full Year 2022

Globus Medical, Inc. to Report Q4, 2021 Results on Feb 17, 2022

Globus Medical, Inc. Announces First ExcelsiusGPS® Cranial Surgery

Globus Medical, Inc. Raises Earnings Guidance for the Full Year 2021

Globus Medical Announces Completion of 20,000 Procedures Utilizing ExcelsiusGPS®

First quarter 2021 earnings released: EPS US$0.45 (vs US$0.26 in 1Q 2020)

Globus Medical, Inc. Raises Earnings Guidance for the Full Year 2021

Full year 2020 earnings released

Revenue beats expectations

Globus Medical, Inc. to Report Q4, 2020 Results on Feb 17, 2021

Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2000 Defensive Index

Globus Medical, Inc. Wins Group Purchasing Agreement with Premier

Globus Medical, Inc. to Report Q3, 2020 Results on Oct 28, 2020

Northwest Specialty Hospital Partners with Globus Medical, Inc to Implement the First Fully Navigated Spinal Surgery for Minimally Invasive Interbody Spine Fusion Procedures

Globus Medical, Inc. (NYSE:GMED) acquired Synoste Oy for $33.3 million.

Globus Medical, Inc. Withdrew Previously Announce Full Year 2020 Guidance

Earnings released

Globus Medical, Inc. to Report Q2, 2020 Results on Aug 05, 2020

Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2000 Defensive Index

Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2500 Growth Index

Globus Medical, Inc.(NYSE:GMED) dropped from Russell 2000 Index

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘